DABT study plan

Define and distinguish toxicity, hazard, exposure, risk, and adverse effect, producing a one-page glossary written from memory.

Construct graded and quantal dose-response curves from supplied data and calculate LD50, ED50, NOAEL, LOAEL, and a benchmark dose with its confidence limits.

Explain receptor-mediated, non-receptor, and covalent-binding mechanisms of toxicant-target interaction and predict the outcome for four worked examples.

Diagram the sequence from exposure through absorption, distribution, and elimination, annotating where defense mechanisms and repair processes intervene.

Classify toxicant interactions (additive, synergistic, potentiation, antagonism) and solve five combination-exposure problems.

Calculate half-life, volume of distribution, clearance, and steady-state concentration from ten plasma time-course data sets.

Compare first-order with zero-order (saturable) elimination and predict how overdose alters half-life, using two worked examples including ethanol or salicylate.

Map Phase I reactions (CYP oxidation, hydrolysis, reduction) and Phase II conjugations (glucuronidation, sulfation, glutathione, acetylation) and predict the principal metabolite for eight substrate structures.

Identify the effect of enzyme induction, inhibition, and genetic polymorphism on bioactivation and detoxification, and list five toxicologically important examples.

Explain how physiologic compartments, protein binding, and transporters alter target-site dose and interpret a physiologically based model output qualitatively.

Differentiate hepatic injury patterns (steatosis, centrilobular necrosis, cholestasis, fibrosis) and link each to a mechanism and a prototype agent.

Trace nephrotoxic insult sites along the nephron and match five agents to their specific site and resulting biomarker.

Explain pulmonary defense mechanisms and predict which inhaled agents bypass which defense and why.

Reconstruct heme biosynthesis and identify the enzymatic step blocked in lead poisoning together with the resulting laboratory pattern.

Select and interpret organ-specific biomarkers for hepatic, renal, and pulmonary injury in three clinical vignettes.

Distinguish central from peripheral neurotoxicity mechanisms and match six agents to their neuronal or glial target.

Apply developmental toxicity principles (critical windows, placental transfer, dose dependency) to interpret a teratology study and identify its NOAEL for maternal and fetal endpoints.

Describe immunotoxic, dermatotoxic, and endocrine-disrupting endpoints and the screening assays used to detect each.

Integrate organ-specific findings into a coherent differential for a multi-organ exposure case and defend the ranking of candidate agents.

Compare the toxicokinetics, mechanism, and target organ of eight metals (lead, mercury, cadmium, arsenic, chromium, nickel, manganese, thallium) and justify the matching chelator or treatment.

Classify pesticides by mechanism of action (organophosphate, carbamate, pyrethroid, neonicotinoid, chlorinated hydrocarbon, herbicide) and predict the clinical syndrome and antidote for each.

Explain solvent neurotoxicity and metabolic activation for five common industrial solvents and predict interaction with alcohol or other coexposures.

Relate physicochemical properties (lipophilicity, volatility, reactivity) to route of exposure and systemic distribution for industrial chemicals.

Predict the toxic syndrome of major drug classes (acetaminophen, salicylates, NSAIDs, opioids, cardiotoxic drugs, antineoplastic agents) and match each to its antidote or management strategy.

Categorize natural toxins (mycotoxins, plant alkaloids, marine biotoxins, venom peptides) by mechanism and food or exposure source.

Differentiate biological toxin classes (botulinum neurotoxin, ricin, tetrodotoxin, cyanide-releasing compounds) by mechanism of action and describe decontamination and treatment.

Explain the mechanism, indication, and limitation of twelve clinically important antidotes and chelators.

Perform the four-step risk assessment on a supplied exposure scenario, deriving a reference dose from a NOAEL or benchmark dose using appropriate uncertainty factors.

Calculate excess cancer risk from a slope factor and estimated dose, and interpret biomonitoring and exposure-assessment data in context.

Evaluate cohort, case-control, and cross-sectional studies for bias, confounding, effect modification, and strength of causal inference.

Outline the scope of major regulatory frameworks (TSCA, FIFRA, FFDCA, REACH, GHS, ICH) and assign the correct agency or framework to ten regulatory scenarios.

Design a 90-day repeat-dose study by selecting species, dose levels, endpoints, and statistical approach, and justify a sentinel and recovery group.

Complete two timed 100-question mixed practice examinations under exam conditions and score 75% or higher on both.

Convert every missed item from weeks 1 through 8 into a flashcard set and retest on it until 90% correct.

Rebuild the organ-system injury matrix, antidote matrix, and dose-response definitions from memory without notes.

Rank the ten weakest subtopics by observed error rate and write a targeted remediation plan for each.